GPX4 and type 2 diabetes mellitus: Poliumoside belongs to phenylpropanoid glycoside and alleviates type 2 diabetes-related osteoporosis by suppressing ferroptosis through activation of the Nrf2/GPX4 pathway, enhancing bone mineral density and mitigating oxidative stress [139].